首页|New Findings on Amyloidosis Described by Investigators at Boston University (Mac hine-learning Based Subgroups of Al Amyloidosis and Cumulative Incidence of Mort ality and End Stage Kidney Disease)
New Findings on Amyloidosis Described by Investigators at Boston University (Mac hine-learning Based Subgroups of Al Amyloidosis and Cumulative Incidence of Mort ality and End Stage Kidney Disease)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-Investigators publish new report on Nu tritional and Metabolic Diseases and Conditions-Amyloidosis. According to news reporting originating from Boston, Massachusetts, by NewsRx correspondents, res earch stated, "Immunoglobulin light chain (AL) amyloidosis is a multisystem dise ase with varied treatment options and disease-related outcomes. Current staging systems rely on a limited number of cardiac, renal, and plasma cell dyscrasia bi omarkers." Financial support for this research came from Amyloid Research Fund of the Bosto n University School of Medicine.
BostonMassachusettsUnited StatesNo rth and Central AmericaAmyloidosisCyborgsEmerging TechnologiesHealth and MedicineMachine LearningMetabolic Diseases and ConditionsNephrologyNutr itional and Metabolic Diseases and ConditionsProteostasis DeficienciesBoston University
NETL
NSTL
